NASDAQ:LBIO Shareholder News: Lawsuit Against Lion Biotechnologies Inc Seeks to Recover Losses
An investor, who purchased shares of Lion Biotechnologies Inc (NASDAQ:LBIO), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged Securities Laws violations by Lion Biotechnologies Inc.
View full press release